ESR2 and breast carcinoma: With less homology with ER-α, LBD represents the characteristics of ER-β; however, the presence of variant forms, and the lack of robust antibodies for each ER-β variant, complicates the biological and clinical importance of ER-β specifically in breast cancer [29,66].